ABOUT THIS EPISODE
On November 12, 2026, the U.S. Food and Drug Administration granted Breakthrough Therapy designation to Clarity Pharmaceuticals' Cu-64 SAR-bisPSMA, making it the first PSMA PET imaging agent ever to receive that designation. Clarity Pharmaceuticals is an Australian clinical-stage radiopharmaceutical company listed on the ASX under the ticker CU6.
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OTHER EPISODES IN THIS PODCAST
On November 6, 2026, at approximately 8:30–8:37 p.m., a Ring doorbell camera at an off-campus apartment captured two white University of Mississippi (Ole Miss) students making monkey-like gestures and chest-beating sounds outside the door of three Black students — freshmen Jakiyra Metcalf, Kaiyden …
The "resource curse" describes a well-documented pattern in which countries endowed with abundant extractable natural resources—oil, gas, minerals, diamonds—frequently exhibit weaker institutional development and slower economic growth than resource-poor counterparts.
Todrick Hall, a Black writer, director, and performer, created an off-Broadway musical titled Midnight, staging it at New York's Daryl Roth Theatre. The production uses the American slavery era as its setting for a romantic narrative, featuring a second act that inverts the racial hierarchy — placi…
Nations face a durable structural tension rooted in political economy: economic integration through trade, supply chains, and capital flows generates efficiency gains and prosperity via specialization and comparative advantage, but simultaneously constrains autonomous policymaking and exposes count…
Disclaimer: The podcast and artwork embedded on this page are from Onpode, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
